Business Context and Reporting Period
Company: Nano Nuclear Energy Inc. (NNE)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter ended June 30, 2024 (Nine months ended June 30, 2024)
Business Overview: An early-stage, pre-revenue nuclear energy company developing portable micro nuclear reactors (ZEUS and ODIN), a domestic HALEU fuel fabrication facility, and HALEU transportation solutions. The company also plans to offer nuclear service support and consultation.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2024 |
Nine Months Ended June 30, 2024 |
As of June 30, 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | N/A |
| Net Loss | $(4,668,247) | $(7,659,820) | N/A |
| Operating Expenses | $4,706,619 | $7,769,379 | N/A |
| Cash and Cash Equivalents | N/A | N/A | $13,789,532 |
| Working Capital | N/A | N/A | $12,513,828 |
| Accumulated Deficit | N/A | N/A | $(14,942,045) |
| Total Liabilities | N/A | N/A | $3,424,402 |
| Shares Outstanding | N/A | N/A | 30,127,663 (as of Aug 13, 2024) |
Material Changes vs. Prior Period
- Revenue: Remained at $0; the company is pre-revenue.
- Net Loss: Increased significantly to $4.67M for the quarter (vs. $2.70M prior year) and $7.66M for the nine months (vs. $4.90M prior year).
- Operating Expenses:
- R&D Expenses: Rose 205% quarter-over-quarter to $2.02M, primarily driven by the acquisition of ALIP technology (expensed as in-process R&D).
- G&A Expenses: Increased 13% quarter-over-quarter to $2.30M due to additional staff and office costs.
- Contingent Consideration: A new expense of $385,500 was recorded due to the revaluation of contingent consideration related to the ALIP acquisition.
- Liquidity: Cash balances increased from $6.95M (Sept 30, 2023) to $13.79M (June 30, 2024), driven by financing activities including the May 2024 IPO.
- Equity Structure: Mezzanine equity of $5.0M (redeemable shares) was converted to permanent stockholders' equity in March 2024.
Guidance, Outlook, Risks, and Unusual Items
- Capital Raise (Subsequent Event): In July 2024, the company completed a follow-on offering generating approximately $18.0M in gross proceeds, plus an over-allotment generating $2.70M. Total net proceeds from this event were approximately $21.3M.
- Strategic Outlook: Management plans to spend approximately $9M over the next 12 months on R&D ($4M) and administrative support ($5M). The company targets microreactor licensing between 2026-2031 and commercial launch around 2031.
- Acquisition Activity: Acquired ALIP technology (annular linear induction pump) for a total purchase price of ~$1.67M (cash and stock), with contingent consideration revalued to $1.22M at quarter-end.
- Legal Proceedings: A putative securities class action lawsuit was filed on August 9, 2024, alleging violations of federal securities laws regarding statements on microreactor development. The company disputes the allegations.
- Risk Factors: The company is an emerging growth company with no revenue. Continued solvency depends on raising additional capital. There is no assurance that microreactors will be licensed or commercialized on the projected timeline.
Investor Verification Checklist
- Capital Sufficiency: Verify if the ~$21.3M raised in July 2024 is sufficient to fund the projected $9M annual burn rate and long-term R&D needs without further dilution.
- Revenue Timeline: Confirm the feasibility of generating revenue from consulting services by the end of 2024, as the company currently has no revenue streams.
- Legal Exposure: Monitor the status of the August 2024 securities class action lawsuit and potential financial impact.
- Regulatory Milestones: Track progress on NRC licensing for the ZEUS and ODIN microreactors and the HALEU fuel fabrication facility.
- Contingent Liabilities: Review the volatility of the $1.22M contingent consideration liability tied to the ALIP acquisition, which fluctuates with stock price.